Hims & Hers Q2 revenue beat offset by wider-than-expected loss

5 days ago 9

Proactive

Tue, August 11, 2026 astatine 10:35 AM CDT 2 min read

Hims & Hers Q2 gross  bushed  offset by wider-than-expected loss

Hims & Hers Q2 gross bushed offset by wider-than-expected nonaccomplishment Proactive uses images sourced from Shutterstock

Hims & Hers Health (NYSE:HIMS) delivered mixed second-quarter results, with gross beating Wall Street expectations portion its quarterly nonaccomplishment came successful wider than analysts had forecast arsenic the institution incurred restructuring charges tied to its displacement toward branded GLP-1 weight-loss options.

Revenue for the 4th ended June 30 roseate 38% twelvemonth implicit twelvemonth to $753.2 million, topping the astir $699 cardinal analysts had expected. The institution reported a nonaccomplishment of $0.37 per share, compared with expectations for a nonaccomplishment of astir $0.05 per share.

Total subscribers accrued 19% twelvemonth implicit twelvemonth to astir 2.9 million.

"Our 2nd 4th results were defined by a important re-acceleration successful our maturation illustration and the continued expanding scope of our platform," Hims & Hers CFO Yemi Okupe said successful a statement..

"Domestic gross maturation accelerated to 16% year-over-year, and our planetary concern grew much than 17-fold, strengthened by the adjacent of our Eucalyptus acquisition successful June."

The institution raised its full-year 2026 gross outlook to betwixt $3.1 cardinal and $3.3 billion, from its erstwhile guidance, and forecast adjusted EBITDA of $275 cardinal to $325 million, representing an adjusted EBITDA borderline of 9% to 10%.

For the 3rd quarter, Hims & Hers expects gross of $880 cardinal to $900 cardinal and adjusted EBITDA of $75 cardinal to $95 million, implying an adjusted EBITDA borderline of 9% to 11%.

Hims & Hers CEO Andrew Dudum said the institution was focused connected expanding its wellness level and processing what it described arsenic a doctor-led AI objective engine.

"We person ne'er been amended positioned to determination faster oregon spell further than we are today," Dudum said. "As we rebuild the user wellness acquisition from the crushed up with a doctor-led AI objective engine, the extent and breadth of our relationships with customers worldwide has ne'er been greater."

Shares of Hims & Hers were down astir 1% pursuing the results.

Read Entire Article